Ontology highlight
ABSTRACT: The title compound (systematic name
2-{2-[4-(dibenzo[b,f][1,4]thia-zepin-11-yl)piperazin-1-yl 1-oxide]eth-oxy}ethanol-fumaric acid (2/1)), C(21)H(25)N(3)O(3)S·0.5C(4)H(4)O(4), is one of the oxidation products of quetiapine hemifumaric acid. In the tricyclic fragment, the central thia-zepine ring displays a boat conformation and the benzene rings are inclined to each other at a dihedral angle of 72.0?(2)°. The piperazine ring adopts a chair conformation with its eth-oxy-ethanol side chain oriented equatorially. In addition to the main mol-ecule, the asymmetric unit contains one-half mol-ecule of fumaric acid, the complete mol-ecule being generated by inversion symmetry. In the crystal, O-H?O hydrogen bonds link the components into corrugated layers parallel to bc plane.
SUBMITTER: Shen J
PROVIDER: S-EPMC3379340 | biostudies-literature | 2012 Jun
REPOSITORIES: biostudies-literature
Shen Jin J Qian Jing-Jing JJ Wu Su-Xiang SX Gu Jian-Ming JM Hu Xiu-Rong XR
Acta crystallographica. Section E, Structure reports online 20120516 Pt 6
<h4>The title compound (systematic name</h4>2-{2-[4-(dibenzo[b,f][1,4]thia-zepin-11-yl)piperazin-1-yl 1-oxide]eth-oxy}ethanol-fumaric acid (2/1)), C(21)H(25)N(3)O(3)S·0.5C(4)H(4)O(4), is one of the oxidation products of quetiapine hemifumaric acid. In the tricyclic fragment, the central thia-zepine ring displays a boat conformation and the benzene rings are inclined to each other at a dihedral angle of 72.0 (2)°. The piperazine ring adopts a chair conformation with its eth-oxy-ethanol side chain ...[more]